An updated guide to treating stroke

  • N Schellack Sefako Makgatho Health Sciences University
  • N Smith Sefako Makgatho Health Sciences University
  • L Van Tonder Netcare Femina Hospital
  • E J Fourie Sefako Makgatho Health Sciences University
Keywords: stroke, hypertension, ischaemic stroke, haemorrhagic stroke, reperfusion, tissue plasminogen activator

Abstract

Stroke is one of the leading causes of mortality worldwide. Stroke can either be haemorrhagic (13%) or ischaemic (87%) in nature. Within the first few days of stroke, transient ischaemic attacks may occur and will require urgent intervention. However, this is often missed by healthcare workers. This article outlines the current evidence-based practice for stroke management and care. Based on the aetiology, this may include early reperfusion with a tissue plasminogen activator (t-PA), antiplatelet therapy and warfarin. This paper outlines many of the recommendations of the published National Clinical Guidelines for Stroke. It also covers aspects of multidisciplinary stroke care, from initial assessment and acute treatment, to rehabilitation strategies and the management of complications.

Author Biographies

N Schellack, Sefako Makgatho Health Sciences University

School of Pharmacy, Sefako Makgatho Health Sciences University, South Africa

N Smith, Sefako Makgatho Health Sciences University

School of Pharmacy, Sefako Makgatho Health Sciences University, South Africa

L Van Tonder, Netcare Femina Hospital

Netcare Femina Hospital, South Africa

E J Fourie, Sefako Makgatho Health Sciences University

School of Pharmacy, Sefako Makgatho Health Sciences University, South Africa

Published
2020-08-31
Section
Reviews